Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma injections can effectively treat stubborn alopecia areata.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

The document concludes that proper diagnosis and treatment of nonscarring alopecias can improve quality of life and hair regrowth is possible as the hair follicle remains intact.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Platelet-rich plasma can increase hair density and may help treat some skin conditions, but it's costly, not FDA-approved, and needs more research.

Minoxidil was more effective than laser therapy for hair loss, and the report also highlighted the need for more research on PRP for a different hair loss condition, the impact of social media on alopecia views, and a warning on turmeric causing nail discoloration.

Hair loss in males involves inflammation, collagen buildup, and follicle damage, with severity increasing with age and baldness duration.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Hair transplantation may work for some types of scarring alopecia, but results vary and more research is needed.

OCT can effectively screen and diagnose various medical conditions non-invasively.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Increased mucin in the skin might indicate lupus in patients with hair loss, but more research is needed.

An alternating inflatable head pad reduced pressure ulcers and hair loss in heart surgery patients.

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

CGF therapy may help hair regrowth and improve scars in DLE patients.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

A woman has a permanent hair loss condition treated with steroids and new medicines, but hair might not regrow.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

Frontal fibrosing alopecia causes hair loss at the front hairline, and no effective treatment exists.

The treatment didn't work for the woman's hair loss and skin darkening.

Alopecia areata is caused by the immune system attacking hair follicles.